Drug Discovery Technologies

Table of Contents

Chapter 1 Introduction

Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst’s Credentials
BCC Custom Research
Related BCC Research Reports

Chapter 2 Summary and Highlights

Market Highlights: Drug Discovery Technologies

Chapter 3 Impact of COVID-19 Pandemic

Introduction
Outbreak
Symptoms of COVID-19
Progression of COVID-19

• Spread of Disease

Impact on Medical Device Market

• Elective and Noncritical Procedures
• Shift in Manufacturing
• Regulatory Delays, Clinical Trials and Product Launches
• Supply Chain Disruptions
• Medical Tourism

Impact of COVID-19 on Pharma Supply Chain
Impact of COVID-19 on the Global Economy
Government Expenditure on COVID-19
Impact on Insurance Providers
Impact of COVID-19 on Drug Discovery Technologies Industry

• Clinical Trials on Hold
• New Reality for Ongoing Studies
• Ensuring Access to Study Drugs

Chapter 4 Market and Technology Background

Some Related Terms

• Toxicity
• Metabolism
• Analytical Chemistry
• Pharmacokinetics
• Pharmacodynamics

Introduction
Process of Drug Discovery
History of Drug Discovery
Classification of Techniques Used in Drug Discovery

• High-throughput Screening
• Bioanalytical Instruments for Drug Discovery
• Cell-based Assays and Reagents for Drug Discovery
• Proteomics Drug Discovery Technologies
• Genomics Drug Discovery Technologies
• Bioinformatics as Platform for Drug Discovery
• Others: Metabolomics-based Technologies, Combinatorial Chemistry, Systems Biology, Nanotechnology

Chapter 5 Market Breakdown by Technology Type

Global Market for Drug Discovery Technologies, by Type
High-Throughput Screening (HTS)

• Market Size and Forecast
• Market Analysis

Bioanalytical Instruments for Drug Discovery

• Market Size and Forecast
• Market Analysis

Cell-Based Assays and Reagents for Drug Discovery

• Market Size and Forecast
• Market Analysis

Proteomics Drug Discovery

• Market Size and Forecast
• Market Analysis

Genomics Drug Discovery

• Market Size and Forecast
• Market Analysis

Bioinformatics as Platform for Drug Discovery

• Market Size and Forecast
• Market Analysis

Others Drug Discovery Technologies

• Market Size and Forecast
• Market Analysis

Chapter 6 Market Breakdown by Disease Application

Global Market for Drug Discovery Technologies, by Disease Application
Cancer Diseases

• Market Size and Forecast
• Market Analysis

Cardiovascular Diseases

• Market Size and Forecast
• Market Analysis

Immunological Diseases

• Market Size and Forecast
• Market Analysis

Neurological Diseases

• Market Size and Forecast
• Market Analysis

Others

• Market Size and Forecast
• Market Analysis

Chapter 7 Market Breakdown by End-user

Global Market for Drug Discovery Technologies, by End-user
Biopharmaceutical Companies

• Market Size and Forecast
• Market Analysis

Research and Academia

• Market Size and Forecast
• Market Analysis

Contract Research Organizations (CROs)

• Market Size and Forecast
• Market Analysis

Chapter 8 Market Breakdown, by Region

Global Market for Drug Discovery Technologies, by Region
North America
Europe
Asia-Pacific
Rest of the World

Chapter 9 Industry Structure

High-Throughput Screening
Bioanalytical Instruments
Cell-Based Assays and Reagents
Proteomics
Genomics
Bioinformatics
Other Drug Discovery Technologies

Chapter 10 Patent Review/New Developments/Regulatory Aspects

Patent Review

• Patents by Year
• Patents by Type
• Patents by Company
• Patents by Country
• Patents by Assignee

Products and Developments

• Mergers and Acquisitions
• Awards for Drug Discovery Technologies

Regulatory Aspects

Chapter 11 Analysis of Market Opportunities

Factors Affecting the Drug Discovery Technologies Market

• Drivers of the Drug Discovery Technologies Market
• Current Challenges for the Drug Discovery Technologies Market

Chapter 12 Company Profiles

AGILENT TECHNOLOGIES INC.
AMETEK INC.
ARRAYIT CORP.
BECKTON, DICKINSON AND CO. (BD BIOSCIENCES)
BIOMAX INFORMATICS AG
BIO-RAD LABORATORIES
BRUKER CORP.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
CODEX BIOSOLUTIONS INC.
DANAHER CORP.
GENERAL ELECTRIC CO.
HITACHI HIGH-TECHNOLOGIES CORP.
ILLUMINA, INC.
INTEGRATED DNA TECHNOLOGIES, INC.
JEOL USA, INC.
LECO CORP.
MERCK KGAA (EMD MILLIPORE)
MULTISPAN INC.
PERKINELMER INC.
PROMEGA CORP.
QIAGEN N.V.
ROCHE HOLDING LTD.
SHIMADZU CORP.
THERMO FISHER SCIENTIFIC

Chapter 13 Appendix: List of Acronyms

List of Tables

Summary Table : Global Market for Drug Discovery Technologies, by Type, Through 2025
Table 1 : Distribution of COVID-19 Clinical Symptoms
Table 2 : Expenditures on COVID-19 Crisis, by Selected Country
Table 3 : Interim Economic Outlook Forecasts, by Country/Region, 2019-2021
Table 4 : History of Drug Discovery
Table 5 : Cell Biology Reagents and Their Functions
Table 6 : Protein Microarrays and Their Functions
Table 7 : Differences Between Solid-Phase and Solution-Phase Synthesis
Table 8 : Global Market for Drug Discovery Technologies, by Type, Through 2025
Table 9 : Global Market for Bioanalytical Instruments and Technology, by Type, Through 2025
Table 10 : Global Market for Cell-Based Assays and Reagents, by Type, Through 2025
Table 11 : Global Market for Proteomics Drug Discovery Technology, by Type, Through 2025
Table 12 : Global Market for Genomic Drug Discovery Technology, by Type, Through 2025
Table 13 : Global Market for Drug Discovery Technologies, by Disease Application, Through 2025
Table 14 : Global Market for Drug Discovery Technologies, by End-User, Through 2025
Table 15 : Global Market for Drug Discovery Technologies, by Region, Through 2025
Table 16 : North American Market for Drug Discovery Technologies, by Country, Through 2025
Table 17 : North American Market for Drug Discovery Technologies, by Type, Through 2025
Table 18 : North American Market for Drug Discovery Technologies, by Disease Application, Through 2025
Table 19 : North American Market for Drug Discovery Technologies, by End-User, Through 2025
Table 20 : European Market for Drug Discovery Technologies, by Country, Through 2025
Table 21 : European Market for Drug Discovery Technologies, by Type, Through 2025
Table 22 : European Market for Drug Discovery Technologies, by Disease Application, Through 2025
Table 23 : European Market for Drug Discovery Technologies, by End-User, Through 2025
Table 24 : Asia-Pacific Market for Drug Discovery Technologies, by Country, Through 2025
Table 25 : Asia-Pacific Market for Drug Discovery Technologies, by Type, Through 2025
Table 26 : Asia-Pacific Market for Drug Discovery Technologies, by Disease Application, Through 2025
Table 27 : Asia-Pacific Market for Drug Discovery Technologies, by End-User, Through 2025
Table 28 : Rest of the World Market for Drug Discovery Technologies, by Type, Through 2025
Table 29 : Rest of the World Market for Drug Discovery Technologies, by Disease Application, Through 2025
Table 30 : Rest of the World Market for Drug Discovery Technologies, by End-User, Through 2025
Table 31 : Manufacturers/Suppliers of High-Throughput Screening Technology
Table 32 : Manufacturers/Suppliers of Bioanalytical Instruments
Table 33 : Manufacturers/Suppliers of Cell-Based Assays and Reagents
Table 34 : Manufacturers/Suppliers of Proteomics Technology
Table 35 : Manufacturers/Suppliers of Genomics Technology
Table 36 : Manufacturers/Suppliers of Bioinformatics Technology
Table 37 : Manufacturers/Suppliers of Other Drug Discovery Technologies
Table 38 : Patents Issued for Drug Discovery Technologies, by Year, January 2016-June 2017
Table 39 : Patents Issued for Drug Discovery Technologies, by Type, January 2016-June 2017
Table 40 : Patents Issued for Drug Discovery Technologies, by Company, January 2016- June 2017
Table 41 : Patents Issued for Drug Discovery Technologies, by Country, January 2016- June 2017
Table 42 : Patents Issued for Drug Discovery Technologies, by Assignee, January 2016- June 2017
Table 43 : Developments for Drug Discovery Technologies
Table 44 : Mergers and Acquisitions of Drug Discovery Technologies Companies
Table 45 : Awards for Drug Discovery Technologies Products
Table 46 : Acronyms Used in the Drug Discovery Technologies Industry

List of Figures

Summary Figure A : Global Market for Drug Discovery Technologies, by Type, 2019-2025
Summary Figure B : Global Market Shares of Drug Discovery Technologies, by Type, 2020
Figure 1 : Comparison of GDP Growth, by Country, 2019 and 2020
Figure 2 : Process of Drug Discovery
Figure 3 : Global Market Shares of Drug Discovery Technologies, by Type, 2020
Figure 4 : Global Market for High-Throughput Screening, 2019-2025
Figure 5 : Global Market for Bioanalytical Instruments for Drug Discovery, 2019-2025
Figure 6 : Global Market for Cell-Based Assays and Reagents for Drug Discovery, 2019-2025
Figure 7 : Global Market for Proteomics Drug Discovery, 2019-2025
Figure 8 : Global Market for Genomics Drug Discovery, 2019-2025
Figure 9 : Global Market for Bioinformatics as Platform for Drug Discovery, 2019-2025
Figure 10 : Global Market for Others Drug Discovery Technologies, 2019-2025
Figure 11 : Global Market Shares of Drug Discovery Technologies, by Disease Application, 2020
Figure 12 : Global Market for Drug Discovery Technologies for Cancer Diseases, 2019-2025
Figure 13 : Global Market for Drug Discovery Technologies for Cardiovascular Diseases, 2019-2025
Figure 14 : Global Disease Burden, 2017
Figure 15 : Global Market for Drug Discovery Technologies for Immunological Diseases, 2019-2025
Figure 16 : Global Market for Drug Discovery Technologies for Neurological Diseases, 2019-2025
Figure 17 : Global Market for Drug Discovery Technologies for Other Diseases, 2019-2025
Figure 18 : Global Market Shares of Drug Discovery Technologies, by End-User, 2020
Figure 19 : Global Market for Drug Discovery Technologies for Biopharmaceutical Companies, 2019-2025
Figure 20 : Global Market for Drug Discovery Technologies for Research and Academia, 2019-2025
Figure 21 : Global Market for Drug Discovery Technologies for Contract Research Organizations, 2019-2025
Figure 22 : Global Market Shares of Drug Discovery Technologies, by Region, 2020
Figure 23 : North American Market for Drug Discovery Technologies, 2019-2025
Figure 24 : North American Market Shares of Drug Discovery Technologies, by Country, 2020
Figure 25 : North American Market Shares of Drug Discovery Technologies, by Type, 2020
Figure 26 : North American Market Shares of Drug Discovery Technologies, by Disease Application, 2020
Figure 27 : North American Market Shares of Drug Discovery Technologies, by End-User, 2020
Figure 28 : European Market for Drug Discovery Technologies, 2019-2025
Figure 29 : European Market Shares of Drug Discovery Technologies, by Country, 2020
Figure 30 : European Market Shares of Drug Discovery Technologies, by Type, 2020
Figure 31 : European Market Shares of Drug Discovery Technologies, by Disease Application, 2020
Figure 32 : European Market Shares of Drug Discovery Technologies, by End-User, 2020
Figure 33 : Asia-Pacific Market for Drug Discovery Technologies, 2019-2025
Figure 34 : Asia-Pacific Market Shares of Drug Discovery Technologies, by Country, 2020
Figure 35 : Asia-Pacific Market Shares of Drug Discovery Technologies, by Type, 2020
Figure 36 : Asia-Pacific Market Shares of Drug Discovery Technologies, by Disease Application, 2020
Figure 37 : Asia-Pacific Market Shares of Drug Discovery Technologies, by End-User, 2020
Figure 38 : Rest of the World Market for Drug Discovery Technologies, 2019-2025
Figure 39 : Rest of the World Market Shares of Drug Discovery Technologies, by Type, 2020
Figure 40 : Rest of the World Market Shares of Drug Discovery Technologies, by Disease Application, 2020
Figure 41 : Rest of the World Market Shares of Drug Discovery Technologies, by End-User, 2020
Figure 42 : Patents Issued for Drug Discovery Technologies, by Year, January 2016-June 2017
Figure 43 : Patents Issued for Drug Discovery Technologies, by Type, January 2016-June 2017
Figure 44 : Patents Issued for Drug Discovery Technologies, by Assignee, January 2016- June 2017
Figure 45 : Steps from Drug Discovery to Regulatory Approval
Figure 46 : Agilent: Annual Revenue, 2018-2020
Figure 47 : Agilent: Revenue Share, by Region, 2020
Figure 48 : Agilent: Revenue Share, by Segment, 2020
Figure 49 : Ametek: Annual Revenue, 2017-2019
Figure 50 : Ametek: Revenue Share, by Segment, 2019
Figure 51 : Bio-Rad Laboratories: Annual Revenue, 2017-2019
Figure 52 : Bio-Rad Laboratories: Revenue Share, by Region, 2019
Figure 53 : Bio-Rad Laboratories: Revenue Share, by Segment, 2019
Figure 54 : Bruker Corp.: Annual Revenue, 2018 and 2019
Figure 55 : Bruker: Revenue Share, by Region, 2019
Figure 56 : Bruker Corp.: Revenue Share, by Segment, 2019
Figure 57 : Charles River Laboratories International Inc.: Annual Revenue, 2018-2020
Figure 58 : Charles River Laboratories International Inc.: Revenue Share, by Segment, 2020
Figure 59 : Danaher Corp.: Annual Revenue, 2017-2019
Figure 60 : Danaher Corp.: Revenue Share, by Region/Economies, 2019
Figure 61 : Danaher Corp.: Revenue Share, by Segment, 2019
Figure 62 : General Electric Co.: Annual Revenue, 2019-2020
Figure 63 : General Electric Co.: Revenue Share, by Segment, 2020
Figure 64 : Hitachi High-Technologies: Annual Revenue, 2018 and 2019
Figure 65 : Illumina: Annual Revenue, 2018-2020
Figure 66 : Illumina: Revenue Share, by Region, 2020
Figure 67 : Illumina: Revenue Share, by Segment, 2020
Figure 68 : Merck KGaA: Annual Revenue, 2018-2019
Figure 69 : Merck KGaA: Revenue Share, by Region, 2019
Figure 70 : Merck KGaA: Revenue Share, by Business Sector, 2019
Figure 71 : PerkinElmer: Annual Revenue, 2017-2019
Figure 72 : PerkinElmer: Revenue Share, by Region, 2019
Figure 73 : Qiagen: Annual Revenue, 2017-2019
Figure 74 : Qiagen: Revenue Share, by Region, 2019
Figure 75 : Qiagen: Revenue Share, by Segment, 2019
Figure 76 : Thermo Fisher Scientific: Annual Revenue, 2017-2019
Figure 77 : Thermo Fisher Scientific: Revenue Share, by Segment, 2019

当レポートのプレスリリースは発行されておりません。